Company intelligence / Profile preview

LifeSpan BioSciences

Seattle, Washington, United Stateslsbio.com ↗

Ownership: Private
Development stage: Commercial

Overview

LSBio offers over 750,000 reagent antibodies, assay kits, proteins and biochemicals. It specializes in IHC validated primary antibodies with more than 15,000 identified as exceptional IHC reagents under the IHC-plus™ brand. The company has expanded through acquisitions such as Everest Biotech and Nordic-MUbio to broaden its catalog to include virtually every protein in the proteome.

Therapeutic areas: Other
Modalities: AntibodyProtein (as research reagents)Assay kit (as research tools)Biochemical (as research tools)
Industry: Chemicals & Materials

Partnerships

Extensive network of international distributorsno specific major pharma/biotech partnerships listed

Beyond the preview

Go deeper on LifeSpan BioSciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LifeSpan BioSciences.

Explore the full profile